TELO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Telomir Pharmaceuticals Inc (TELO) is not a strong buy at this moment for a beginner investor with a long-term strategy. The lack of positive financial performance, absence of significant trading trends, and no clear technical or proprietary trading signals suggest that holding off on investment is a more prudent choice. Additionally, the stock's projected short-term negative trend further supports this decision.
The MACD is slightly positive but contracting, indicating a lack of strong momentum. RSI is neutral at 50.666, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 1.327, with resistance at 1.422 and support at 1.231. Overall, technical indicators suggest a neutral stance with no strong buy signal.
NULL identified. No recent news or significant insider/hedge fund activity.
The stock is projected to decline by -0.97% in the next day, -2.11% in the next week, and -4.3% in the next month. Financial performance shows a significant decline in net income (-28.88% YoY) and EPS (-40.00% YoY).
In Q4 2025, revenue remained at 0 with no growth. Net income dropped to -2,061,193 (-28.88% YoY), and EPS fell to -0.06 (-40.00% YoY). Gross margin also showed no improvement, remaining at 0.
No analyst rating or price target changes available.
